Liver Disease
Conference Coverage
Alcohol-related liver disease severity increased during COVID-19 pandemic
Increased alcohol sales and disrupted services may have led to worse clinical outcomes.
From the AGA Journals
Updated MELD score adds serum albumin, female sex
Despite the utility of the current MELD score, questions have been raised concerning the accuracy of the its ability to predict wait list...
From the Journals
Maraviroc, metformin fail to control NAFLD in people with HIV
“As yet, the only thing that is proven to have a very positive effect that is published is weight loss.”
From the Journals
AGA Clinical Practice Guideline: Coagulation in cirrhosis
Clinical complexity and a lack of data make for challenging decisions.
From the Journals
Noninvasive ELF test identifies risk of advanced fibrosis in NAFLD
When combined with the fibrosis-4 score, the ELF test may be a reliable method that can assess for advanced fibrosis in clinical practice.
From the Journals
Drink up: Large study confirms coffee beneficial to liver health
“This is the closest we’re ever going to get to a linkage between what people are eating or drinking and the health of their liver.”
From the Journals
AGA Section: Gastroenterology and hepatology training milestones
Milestones 2.0 provide more clarity for programs, faculty, and fellows and could be used to fill gaps.
Private Practice Perspectives
The importance of education and screening for nonalcoholic fatty liver disease
The number of patients we see with NALFD and NASH continues to rise, and it’s taking its toll.
From the Journals
MRE plus FIB-4 beats FAST for detecting NASH-related fibrosis
Researchers hope to improve prognosis and recruitment to clinical trials.
From the Journals
How do alcohol, obesity impact cirrhosis?
A new analysis suggests that, while alcohol and obesity are risk factors for morbidity, they don’t combine for a stronger effect.